Fexofenadine, Pseudoephedrine

Cloridrato de Fexofenadina+Cloridrato de Pseudoefedrina

BrazilCancelledAuthorised 14 May 2012

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Allegra-DCanada · 60 MG + 120 MG · Tablet (Immediate- And Extended-Release) · Sanofi Consumer Health INCSame substance
Telfast D TabletSingapore · 60 mg + 120 mg · tablet, film coated · Opella Healthcare Singapore Pte. LTD.Same substance
Allegra-D 12 Hour Allergy and CongestionUnited States · 60MG; 120MG · tablet, extended release · Chattem SanofiSame substance
Allegra-D 24 Hour Allergy and CongestionUnited States · 180MG; 240MG · tablet, extended release · Chattem SanofiSame substance
Fexofenadine Hydrochloride and Pseudoephedrine HydrochlorideUnited States · 180MG; 240MG, 60MG; 120MG · tablet, extended release · Impax PharmsSame substance

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Fexofenadine, Pseudoephedrine

Cloridrato de Fexofenadina+Cloridrato de Pseudoefedrina

BrazilCancelledAuthorised 14 May 2012

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Fexofenadine, Pseudoephedrine
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 14 May 2012
Registration: 101810627
Marketing authorisation holder: Medley Indústria Farmacêutica Ltda
Procedure: Registered

Anvisa

Allexofedrin DFexofenadine + PseudoephedrineBrazil

cloridrato de fexofenadina + cloridrato de pseudoefedrinaFexofenadine + PseudoephedrineBrazil

Allegra DFexofenadine + PseudoephedrineBrazilCancelled

Cloridrato de Fexofenadina+Cloridrato de PseudoefedrinaFexofenadine + PseudoephedrineBrazilCancelled

Cloridrato de Fexofenadina+PseudoefedrinaFexofenadine + PseudoephedrineBrazilCancelled

Fexo DFexofenadine + PseudoephedrineBrazilCancelled

Rafex DFexofenadine + PseudoephedrineBrazilCancelled